Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as C$0.25 and last traded at C$0.23, with a volume of 270656 shares trading hands. The stock had previously closed at C$0.24.
Voyageur Pharmaceuticals Price Performance
The stock has a market capitalization of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The firm’s 50 day simple moving average is C$0.10 and its 200 day simple moving average is C$0.07.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Evaluate a Stock Before Buying
- Nebius Group: Market Overreaction or Real AI Disruption?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- The Best Way to Invest in Gold Is…
- The How and Why of Investing in Gold Stocks
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
